MAPT and Alzheimer disease: While Aβ accumulation also disrupts glymphatic function,19,20 clinical studies have shown that the co-presence of Aβ and p-tau, rather than Aβ alone, poses stronger cognitive deterioration, suggesting that p-tau is another primary driver in AD progression.21,22